(Q36388658)

13 August 2017

1 reference

title

T-cell immunotherapy for adenoviral infections of stem-cell transplant recipients (English)

1 reference

13 August 2017

1 reference

1 reference

8

Rooney CM

1 reference

13 August 2017

1

Leen AM

1 reference

13 August 2017

7

Heslop HE

1 reference

13 August 2017

4

Huls MH

1 reference

13 August 2017

Myers GD

2

1 reference

13 August 2017

Bollard CM

series ordinal

3

1 reference

13 August 2017

Sili U

series ordinal

5

1 reference

13 August 2017

Gee AP

series ordinal

6

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Annals of the New York Academy of Sciences

13 August 2017

published in

1 reference

13 August 2017

volume

1062

1 reference

13 August 2017

page(s)

104-115

1 reference

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

The impact of adenovirus infection on the immunocompromised host

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Adenoviral infections and a prospective trial of cidofovir in pediatric hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Adenovirus infection after pediatric bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

The adenovirus E3/10.4K-14.5K proteins down-modulate the apoptosis receptor Fas/Apo-1 by inducing its internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Immune responses to adenoviruses: viral evasion mechanisms and their implications for the clinic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Dependence of adenovirus infectivity on length of the fiber shaft domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Efficient infection of primitive hematopoietic stem cells by modified adenovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Quantitative analysis of adenovirus-specific CD4+ T-cell responses from healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

The adenovirus capsid protein hexon contains a highly conserved human CD4+ T-cell epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Adenovirus hexon T-cell epitope is recognized by most adults and is restricted by HLA DP4, the most common class II allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Myeloid blood CD11c(+) dendritic cells and monocyte-derived dendritic cells differ in their ability to stimulate T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Differential immunogenicity of Epstein-Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1358.013

21 January 2018

Identifiers

DOI

10.1196/ANNALS.1358.013

1 reference

13 August 2017

1 reference